US Patent Issued to TEMPUS AI on July 28 for "Techniques for resolving discordant HER2 status in pathology images for diagnosing breast cancer" (Illinois, Florida Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,694,302, issued on July 28, was assigned to TEMPUS AI INC. (Chicago).

"Techniques for resolving discordant HER2 status in pathology images for diagnosing breast cancer" was invented by Joshua S.K. Bell (Chicago), Catherine Igartua (Chicago) and Nike Tsiapera Beaubier (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "Techniques are provided for replacing image assays using real world data and real word evidence RNA-seq analysis for assessing biologic pathways for identifying molecular subtypes. Systems of a methods diagnose HER2 status for a patient, by identifying discordant HER2 status result between the HER2 status from immunohistochemistry (IHC) ...